Serum vascular endothelial growth factor in epithelial ovarian neoplasms: Correlation with patient survival

Gynecologic Oncology

Volumn 74, Issue 2, 1999, Pages 235-240

  Chen, Chi An ^a   Cheng, Wen Fang ^a   Lee, Chien Nan ^a   Chen, Tzer Ming ^a   Kung, Cheng Che S ^a   Hsieh, Fon Jou ^a   Hsieh, Chang Yao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL;

EID: 0032771247     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5418     Document Type: Article

References (22)

1. Pfleiderer A: Diagnosis and staging of ovarian cancer. J Cancer Res Clin Oncol 197:81-88, 1984
2. Rustin GJS: Tumor markers for ovarian cancer. Eur J Cancer 28A:2-3, 1992
3. Sorbe B, Frankendal B, Verses B: Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 59:576-582, 1982
4. Hacker NF, Berek JS. Lagasse LD, Nieberg RK, Elashoff RM: Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 61: 413-420, 1983
5. Malkasian GD Jr, Melton LJ, O'Brien PC, Greene MH: Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol 149:274-284, 1984
6. Swenerton KD, Hislop TG, Spinelli J, LeRiche JC, Yang N, Boyes DA: Ovarian carcinoma: A multivariate analysis of prognostic factors. Obstet Gynecol 65:264-270, 1985
7. Dembo AJ, Bush RS: Choice of preoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys 8:893-897, 1982
8. Damert A, Ikeda E, Risau W: Activator protein 1 binding potentiates the hypoxia induced transcriptional activation of vascular endothelial growth factor expression in C6 glioma cells. J Biochem 327:419-423, 1997
9. Senger DR, Van De Walter L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackson RW, Dvorak AM, Dvorak HF: Vascular permeability factor (VPA,CEGF) in tumor biology. Cancer Metastasis Res 12:303-324, 1993
10. Mattern J, Koomagi R, Volm M: Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73:931-934, 1996
11. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF: Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 74:1105-1115, 1996
12. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo TK: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53:2912-2918, 1993
13. Paley P, Staskus KA, Gebhard K, Moharraj D, Twiggs LB, Carson LF, Ramakrishnan S: Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80:98-106, 1997
14. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G, Kainz C: Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 92:360-363, 1998
15. Sobin LH, Wittekind C: UICC TNM Classification of Malignant Tumors, 5th ed. New York, New York, Wiley-Liss, 1997
16. Cheng WF, Chen CA, Lee CN, Chen TM, Hsieh FJ, Hsieh CY: Vascular endothelial growth factor in cervical carcinoma. Obstet Gynecol 93:761-765, 1999
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Sismondi S, Giardina G, Diamandis EP: Mutant p53 protein overexpression in associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 75:1327-1338, 1995
19. Danielsen T, Rofstad EK. VEGF, bFGF, and EGF in the angiogenesis of human menaloma xenografts. Int J Cancer 76:836-841, 1998
20. Yamamoto S, Konishi I, Mamdai M, Kuroda H, Komatsu T, Nanbu K, Sakakara H, Mori T: Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 76:1221-1227, 1997
21. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G, Kainz C: Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 92:306-303, 1998
22. Hartenbach EM, Olson TA, Goswitz JJ, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S: Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett 121:169-175, 1997